SCHEMBL19449752

SCHEMBL19449752

CCCCC/C(=N\NC(=N)N)c1ccc(Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 1/20 0.51
POLB P06746 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.45
MAPT P10636 4/20 0.44
GAA P10253 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
SLC6A4 P31645 1/20 0.40
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL17560784 0.99 ALDH1A1 (0.50) ALDH1A1KDM4EPOLBSMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL17560785 0.99 ALDH1A1 (0.50) ALDH1A1KDM4EPOLBSMN1; SMN2MAPT
SCHEMBL16224372 0.96 SMN1; SMN2 (0.46) ALDH1A1KDM4EPOLBSMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL16212398 0.94 SMN1; SMN2 (0.45) ALDH1A1KDM4EPOLBSMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL16212397 0.94 SMN1; SMN2 (0.45) ALDH1A1KDM4EPOLBSMN1; SMN2MAPT
SCHEMBL21283424 0.91 ALDH1A1 (0.48) ALDH1A1KDM4EPOLBSMN1; SMN2MAPT
SCHEMBL21882634 0.90 SMN1; SMN2 (0.54) ALDH1A1KDM4EPOLBSMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL17560850 0.89 SMN1; SMN2 (0.53) ALDH1A1KDM4EPOLBSMN1; SMN2MAPT
SCHEMBL21882655 0.89 ALDH1A1 (0.53) ALDH1A1KDM4EPOLBSMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL17560851 0.89 SMN1; SMN2 (0.53) ALDH1A1KDM4EPOLBSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10392363-B2 Methods for treating protozoan infections NEOCULI PTY LTD. (AU) 2019-08-27 US claimed
EP-3188722-B1 METHODS FOR TREATING PROTOZOAN INFECTIONS NEOCULI PTY LTD (AU) 2021-08-04 EP disclosed
US-20170291886-A1 METHODS FOR TREATING PROTOZOAN INFECTIONS NEOCULI PTY LTD (AU) 2017-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170291886-A1 METHODS FOR TREATING PROTOZOAN INFECTIONS DPM1, ABCB11, PIGS ALDH1A1 840/4885KDM4E 3521/4885POLB 3872/4885
US-10392363-B2 Methods for treating protozoan infections DPM1, ABCB11, PIGS ALDH1A1 840/4885KDM4E 3521/4885POLB 3872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.